Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Avecho Biotechnology Ltd

AVE.AX ✓ COMPLIANT ☆ Track — members

ASX · Healthcare · Pharmaceuticals ·

Australia Micro Cap Analyst: N/A

Last Close

$0.02

▼ -8.70%

Market Cap $58.56M · Vol 5.59M

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$58.56M

Micro Cap

Div Yield

N/A

Semi-annual dividend

EPS Growth

N/A

YoY

RSI (14)

50.00

Momentum

Beta

1.61

vs Market

52W High

$0.02

19.35% below

52W Low

$0.00

321.73% above

Volume

5.59M

Avg 4.07M

P/B

21.20

Price-to-book

ROE

N/A

Return on equity

Free Float

72.98%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Avecho Biotechnology Ltd (AVE.AX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does AVE.AX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+0.00%

-4.55%

+75.00%

+90.91%

YTD

+133.33%

+250.00%

+419.13%

+16.67%

Financials & Valuation

TTM · Annual

Total Revenue	$825.83K
Net Income	$-2,946,771.00
Revenue Growth (YoY)	-89.36%
Gross Margin	71.77%
Operating Margin	-319.55%
Net Profit Margin	-356.82%
ROE	N/A
ROA · ROIC	-72.98% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	23.75
P/B	21.20
P/FCF	26.65
EPS Growth	N/A
Outstanding Shares	3.86B

Technical Indicators

50-Day SMA	$0.02
200-Day SMA	$0.01
RSI (14)	50.00
Beta	1.61
52-Week High	$0.02
52-Week Low	$0.00

Volume Today	5.59M
Avg Daily Volume (30D)	4.07M
Relative Volume	1.37x
Volatility (10D)	110.12
Volatility (30D)	102.05
Free Float	72.98%

Analyst Consensus

N/A

Current Price $0.02

Mean Target N/A

52W Low$0.00 52W High$0.02

Current

Target

$0.00 $0.02

Current Analyst target

· 0 analysts

Identifiers

ExchangeASX

FIGIBBG001SCQ4S3

ISINAU0000047441

CountryAustralia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeUNT Unit

Similar Halal Stocks

LLY Eli Lilly and Company -0.11% JNJ Johnson & Johnson -0.27% ABBV AbbVie Inc. +1.63% NVS Novartis AG +0.00% NOVN.S Novartis AG +0.43%

Company Profile

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its proprietary drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from Vitamin E using proprietary and patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol, Veterinary Applications, among others. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.